![](/img/cover-not-exists.png)
P1.12-20 Overall Survival with Lurbinectedin Plus Doxorubicin in Relapsed SCLC. Results from an Expansion Cohort of a Phase Ib Trial
Forster, M., Moreno, V., Calvo, E., Olmedo, M.E., Lopez-Criado, M.P., Lopez-Vilariño, J., Nuñez, R., Kahatt, C., Soto-Matos, A.Volume:
13
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.855
Date:
October, 2018
File:
PDF, 121 KB
2018